Ameritas Advisory Services’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
|
|||||
|
2025
Q1 | $430K | Sell |
|
|||||
|
2024
Q4 | $430K | Buy |
|
|||||
|
2024
Q3 | $438K | Sell |
|
|||||
|
2024
Q2 | $421K | Sell |
|
|||||
|
2024
Q1 | $471K | Sell |
|
|||||
|
2023
Q4 | $596K | Buy |
|
|||||
|
2023
Q3 | $532K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $480K | Buy |
|
|||||
|
2022
Q4 | $462K | Sell |
|
|||||
|
2022
Q3 | $514K | Sell |
|
|||||
|
2022
Q2 | $551K | Sell |
|
|||||
|
2022
Q1 | $661K | Buy |
|
|||||
|
2021
Q4 | $613K | Buy |
|